Symbol="CYTK"
AssetType="Common Stock"
Name="Cytokinetics Inc"
Description="Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California."
CIK="1061983"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="280 EAST GRAND AVENUE, ., SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3070063000"
EBITDA="-475224000"
PERatio="None"
PEGRatio="-0.42"
BookValue="-3.472"
DividendPerShare="0"
DividendYield="0"
EPS="-4.68"
RevenuePerShareTTM="0.105"
ProfitMargin="0"
OperatingMarginTTM="-48.43"
ReturnOnAssetsTTM="-0.388"
ReturnOnEquityTTM="-5.72"
RevenueTTM="9952000"
GrossProfitTTM="-146225000"
DilutedEPSTTM="-4.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.99"
AnalystTargetPrice="61.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.52"
PriceToBookRatio="31.9"
EVToRevenue="21.97"
EVToEBITDA="-13.92"
Beta="0.748"
num_52WeekHigh="55.8"
num_52WeekLow="30.66"
num_50DayMovingAverage="34.2"
num_200DayMovingAverage="38.54"
SharesOutstanding="95641000"
DividendDate="None"
ExDividendDate="None"
symbol="CYTK"
open="32.32"
high="32.73"
low="31.87"
price="32.71"
volume="1165193.00"
latest_trading_day="2023-08-15"
previous_close="32.10"
change="0.61"
change_percent="1.9003%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="84"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="878094"
Change_recent_avg="-0.06"
Delta_recent_avg="1.45"
Variance_recent_avg="0.73"
Change_ratio_recent_avg="-0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="172"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0004.jpeg"
image_negative_thumbnail_id_2="1119"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0152.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="597"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_positive_thumbnail_id_1="603"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0105.jpeg"
image_positive_thumbnail_id_2="989"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
